Skip to main content
Top
Published in: Fibrogenesis & Tissue Repair 1/2010

Open Access 01-12-2010 | Research

Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis

Authors: Sebastian Huss, Jörg Schmitz, Diane Goltz, Hans-Peter Fischer, Reinhard Büttner, Ralf Weiskirchen

Published in: Fibrogenesis & Tissue Repair | Issue 1/2010

Login to get access

Abstract

Background

Computer-based morphometry can minimize subjectivity in the assessment of liver fibrosis. An image processing program was developed with Delphi for the quantification of fibrosis in liver tissue samples stained with Sirius Red. Bile duct ligated and sham operated wild type C57BL/6 mice served as a model of time-dependent induction of liver fibrosis. Formation of fibrosis was determined with the developed software at day 0, 3, 7, 10, 14, 20, 30 and 60. The results were compared to a semi-quantitative scoring system.

Results

Quantitative accumulation of collagen fibres was observed from day 3 to day 14, with a slight further increase thereafter. During ongoing fibrogenesis, there was a significant elevation of alanine aminotransferase (ALT), aspartate transaminase (AST) and bilirubin. The results from our computer-based morphometric analysis were highly correlated with the results that were obtained in a standardized pathology semi-quantitative scoring system (R 2 = 0.89, n = 38).

Conclusions

Using our Delphi-based image analysing software, the morphometric assessment of fibrosis is as precise as semi-quantitative scoring by an experienced pathologist. This program can be a valuable tool in any kind of experimental or clinical setting for standardized quantitative assessment of fibrosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN: Histological grading and staging of chronic hepatitis. J Hepatol. 1995, 22: 696-699. 10.1016/0168-8278(95)80226-6.CrossRefPubMed Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN: Histological grading and staging of chronic hepatitis. J Hepatol. 1995, 22: 696-699. 10.1016/0168-8278(95)80226-6.CrossRefPubMed
2.
go back to reference Brunt EM: Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001, 21: 3-16. 10.1055/s-2001-12925.CrossRefPubMed Brunt EM: Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001, 21: 3-16. 10.1055/s-2001-12925.CrossRefPubMed
3.
go back to reference Diseases of the Bile Ducts. Edited by: Portmann BC, Nakanuma Y. 2007, New York: Churchill Livingstone, 5 Diseases of the Bile Ducts. Edited by: Portmann BC, Nakanuma Y. 2007, New York: Churchill Livingstone, 5
4.
go back to reference Zaitoun AM, Mardini Al H, Awad S, Ukabam S, Makadisi S, Record CO: Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C. J Clin Pathol. 2001, 54: 461-465. 10.1136/jcp.54.6.461.PubMedCentralCrossRefPubMed Zaitoun AM, Mardini Al H, Awad S, Ukabam S, Makadisi S, Record CO: Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C. J Clin Pathol. 2001, 54: 461-465. 10.1136/jcp.54.6.461.PubMedCentralCrossRefPubMed
5.
go back to reference Caballero T, Perez-Milena A, Masseroli M, O'Valle F, Salmeron FJ, Del Moral RM, Sanchez-Salgado G: Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C. J Hepatol. 2001, 34: 740-747. 10.1016/S0168-8278(01)00006-X.CrossRefPubMed Caballero T, Perez-Milena A, Masseroli M, O'Valle F, Salmeron FJ, Del Moral RM, Sanchez-Salgado G: Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C. J Hepatol. 2001, 34: 740-747. 10.1016/S0168-8278(01)00006-X.CrossRefPubMed
6.
go back to reference Dahab GM, Kheriza MM, El-Beltagi HM, Fouda AM, El-Din OA: Digital quantification of fibrosis in liver biopsy sections: description of a new method by Photoshop software. J Gastroenterol Hepatol. 2004, 19: 78-85. 10.1111/j.1440-1746.2004.03183.x.CrossRefPubMed Dahab GM, Kheriza MM, El-Beltagi HM, Fouda AM, El-Din OA: Digital quantification of fibrosis in liver biopsy sections: description of a new method by Photoshop software. J Gastroenterol Hepatol. 2004, 19: 78-85. 10.1111/j.1440-1746.2004.03183.x.CrossRefPubMed
7.
go back to reference Masseroli M, Caballero T, O'Valle F, Del Moral RM, Perez-Milena A, Del Moral RG: Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis. J Hepatol. 2000, 32: 453-464. 10.1016/S0168-8278(00)80397-9.CrossRefPubMed Masseroli M, Caballero T, O'Valle F, Del Moral RM, Perez-Milena A, Del Moral RG: Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis. J Hepatol. 2000, 32: 453-464. 10.1016/S0168-8278(00)80397-9.CrossRefPubMed
8.
go back to reference Abdalla AF, Zalata KR, Ismail AF, Shiha G, Attiya M, Abo-Alyazeed A: Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods. Fibrogenesis Tissue Repair. 2009, 2: 2-10.1186/1755-1536-2-2.PubMedCentralCrossRefPubMed Abdalla AF, Zalata KR, Ismail AF, Shiha G, Attiya M, Abo-Alyazeed A: Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods. Fibrogenesis Tissue Repair. 2009, 2: 2-10.1186/1755-1536-2-2.PubMedCentralCrossRefPubMed
9.
go back to reference Georgiev P, Jochum W, Heinrich S, Jang JH, Nocito A, Dahm F, Clavien PA: Characterization of time-related changes after experimental bile duct ligation. Br J Surg. 2008, 95: 646-656. 10.1002/bjs.6050.CrossRefPubMed Georgiev P, Jochum W, Heinrich S, Jang JH, Nocito A, Dahm F, Clavien PA: Characterization of time-related changes after experimental bile duct ligation. Br J Surg. 2008, 95: 646-656. 10.1002/bjs.6050.CrossRefPubMed
10.
go back to reference Johnstone JM, Lee EG: A quantitative assessment of the structural changes the rat's liver following obstruction of the common bile duct. Br J Exp Pathol. 1976, 57: 85-94.PubMedCentralPubMed Johnstone JM, Lee EG: A quantitative assessment of the structural changes the rat's liver following obstruction of the common bile duct. Br J Exp Pathol. 1976, 57: 85-94.PubMedCentralPubMed
11.
go back to reference Wang H, Vohra BP, Zhang Y, Heuckeroth RO: Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice. Hepatology. 2005, 42: 1099-1108. 10.1002/hep.20903.CrossRefPubMed Wang H, Vohra BP, Zhang Y, Heuckeroth RO: Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice. Hepatology. 2005, 42: 1099-1108. 10.1002/hep.20903.CrossRefPubMed
12.
go back to reference Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, Marschall HU, Tsybrovskyy O, Zatloukal K, Denk H, Trauner M: Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology. 2002, 123: 1238-1251. 10.1053/gast.2002.35948.CrossRefPubMed Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, Marschall HU, Tsybrovskyy O, Zatloukal K, Denk H, Trauner M: Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology. 2002, 123: 1238-1251. 10.1053/gast.2002.35948.CrossRefPubMed
13.
go back to reference Neumeier M, Hellerbrand C, Gabele E, Buettner R, Bollheimer C, Weigert J, Schaffler A, Weiss TS, Lichtenauer M, Scholmerich J, Buechler C: Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis. World J Gastroenterol. 2006, 12: 5490-5494.PubMedCentralPubMed Neumeier M, Hellerbrand C, Gabele E, Buettner R, Bollheimer C, Weigert J, Schaffler A, Weiss TS, Lichtenauer M, Scholmerich J, Buechler C: Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis. World J Gastroenterol. 2006, 12: 5490-5494.PubMedCentralPubMed
14.
go back to reference Arias M, Sauer-Lehnen S, Treptau J, Janoschek N, Theuerkauf I, Buettner R, Gressner AM, Weiskirchen R: Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol. 2003, 3: 29-10.1186/1471-230X-3-29.PubMedCentralCrossRefPubMed Arias M, Sauer-Lehnen S, Treptau J, Janoschek N, Theuerkauf I, Buettner R, Gressner AM, Weiskirchen R: Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol. 2003, 3: 29-10.1186/1471-230X-3-29.PubMedCentralCrossRefPubMed
15.
go back to reference Ludwig J, Dickson ER, McDonald GS: Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol. 1978, 379: 103-112. 10.1007/BF00432479.CrossRefPubMed Ludwig J, Dickson ER, McDonald GS: Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol. 1978, 379: 103-112. 10.1007/BF00432479.CrossRefPubMed
16.
go back to reference Nohlgard C, Rubio CA, Kock Y, Hammar H: Liver fibrosis quantified by image analysis in methotrexate-treated patients with psoriasis. J Am Acad Dermatol. 1993, 28: 40-45. 10.1016/0190-9622(93)70006-F.CrossRefPubMed Nohlgard C, Rubio CA, Kock Y, Hammar H: Liver fibrosis quantified by image analysis in methotrexate-treated patients with psoriasis. J Am Acad Dermatol. 1993, 28: 40-45. 10.1016/0190-9622(93)70006-F.CrossRefPubMed
17.
go back to reference O'Brien MJ, Keating NM, Elderiny S, Cerda S, Keaveny AP, Afdhal NH, Nunes DP: An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. Am J Clin Pathol. 2000, 114: 712-718. 10.1309/D7AU-EYW7-4B6C-K08Y.CrossRefPubMed O'Brien MJ, Keating NM, Elderiny S, Cerda S, Keaveny AP, Afdhal NH, Nunes DP: An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. Am J Clin Pathol. 2000, 114: 712-718. 10.1309/D7AU-EYW7-4B6C-K08Y.CrossRefPubMed
18.
go back to reference Beaussier M, Wendum D, Schiffer E, Dumont S, Rey C, Lienhart A, Housset C: Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries. Lab Invest. 2007, 87: 292-303. 10.1038/labinvest.3700513.CrossRefPubMed Beaussier M, Wendum D, Schiffer E, Dumont S, Rey C, Lienhart A, Housset C: Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries. Lab Invest. 2007, 87: 292-303. 10.1038/labinvest.3700513.CrossRefPubMed
19.
go back to reference Rubin E, Schaffner F, Popper H: Primary Biliary Cirrhosis. Chronic Non-Suppurative Destructive Cholangitis. Am J Pathol. 1965, 46: 387-407.PubMedCentralPubMed Rubin E, Schaffner F, Popper H: Primary Biliary Cirrhosis. Chronic Non-Suppurative Destructive Cholangitis. Am J Pathol. 1965, 46: 387-407.PubMedCentralPubMed
20.
go back to reference Kaplan MM, Gershwin ME: Primary biliary cirrhosis. N Engl J Med. 2005, 353: 1261-1273. 10.1056/NEJMra043898.CrossRefPubMed Kaplan MM, Gershwin ME: Primary biliary cirrhosis. N Engl J Med. 2005, 353: 1261-1273. 10.1056/NEJMra043898.CrossRefPubMed
23.
go back to reference Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn MJ, Adamson MD, Purdie DM, Powell EE: Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology. 2001, 121: 148-155. 10.1053/gast.2001.25480.CrossRefPubMed Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn MJ, Adamson MD, Purdie DM, Powell EE: Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology. 2001, 121: 148-155. 10.1053/gast.2001.25480.CrossRefPubMed
24.
go back to reference Park DH, Baik SK, Choi YH, Kim MY, Rhim DW, Kim JW, Kwon SO, Cho MY, Kim CH, Ahn SC: Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats. Korean J Hepatol. 2007, 13: 61-69.PubMed Park DH, Baik SK, Choi YH, Kim MY, Rhim DW, Kim JW, Kwon SO, Cho MY, Kim CH, Ahn SC: Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats. Korean J Hepatol. 2007, 13: 61-69.PubMed
25.
go back to reference Kountouras J, Billing BH, Scheuer PJ: Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol. 1984, 65: 305-311.PubMedCentralPubMed Kountouras J, Billing BH, Scheuer PJ: Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol. 1984, 65: 305-311.PubMedCentralPubMed
26.
go back to reference Cross SS: Grading and scoring in histopathology. Histopathology. 1998, 33: 99-106. 10.1046/j.1365-2559.1998.00495.x.CrossRefPubMed Cross SS: Grading and scoring in histopathology. Histopathology. 1998, 33: 99-106. 10.1046/j.1365-2559.1998.00495.x.CrossRefPubMed
27.
go back to reference Macnaughton RJ: Numbers, scales and qualitative research. Lancet. 1996, 347: 1099-1100. 10.1016/S0140-6736(96)90286-X.CrossRefPubMed Macnaughton RJ: Numbers, scales and qualitative research. Lancet. 1996, 347: 1099-1100. 10.1016/S0140-6736(96)90286-X.CrossRefPubMed
28.
go back to reference Theise ND BH, Ferrell LD, (Ed): Acute and chronical viral hepatitis. 2007, New York: Churchill Livingstone, 5 Theise ND BH, Ferrell LD, (Ed): Acute and chronical viral hepatitis. 2007, New York: Churchill Livingstone, 5
Metadata
Title
Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis
Authors
Sebastian Huss
Jörg Schmitz
Diane Goltz
Hans-Peter Fischer
Reinhard Büttner
Ralf Weiskirchen
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Fibrogenesis & Tissue Repair / Issue 1/2010
Electronic ISSN: 1755-1536
DOI
https://doi.org/10.1186/1755-1536-3-10

Other articles of this Issue 1/2010

Fibrogenesis & Tissue Repair 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine